Home  |  Contact

Cellosaurus SK-GT-2 (CVCL_2194)

[Text version]

Cell line name SK-GT-2
Synonyms SKGT2
Accession CVCL_2194
Resource Identification Initiative To cite this cell line use: SK-GT-2 (RRID:CVCL_2194)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
From: Memorial Sloan Kettering Cancer Center; New York; USA.
Population: Hispanic.
Doubling time: 44 hours (PubMed=8334620); ~48 hours (DSMZ); ~44 hours (ECACC).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Transcriptome analysis.
Derived from sampling site: Stomach; fundus.
Sequence variations Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=7665247; CCLE; Cosmic-CLP).
Genome ancestry Source: PubMed=30894373

Origin% genome
Native American14.81
East Asian, North2.09
East Asian, South0
South Asian0
European, North30.94
European, South31.83
Disease Gastric fundus carcinoma (NCIt: C8398)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_8114 (SK-GT-5)
Sex of cell Male
Age at sampling 72Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DepMap; DSMZ; ECACC

Penta D9
Penta E15,17

Run an STR similarity search on this cell line

PubMed=8334620; DOI=10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L
Altorki N., Schwartz G.K., Blundell M., Davis B.M., Kelsen D.P., Albino A.P.
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Cancer 72:649-657(1993)

PubMed=7665247; DOI=10.1002/ijc.2910640109
Nabeya Y., Loganzo F. Jr., Maslak P., Lai L., de Oliveira A.R., Schwartz G.K., Blundell M.L., Altorki N.K., Kelsen D.P., Albino A.P.
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
Int. J. Cancer 64:37-46(1995)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

Cell line collections DSMZ; ACC-702
ECACC; 11012008
Cell line databases/resources CCLE; SKGT2_STOMACH
Cell_Model_Passport; SIDM00393
Cosmic-CLP; 1503364
DepMap; ACH-001653
Biological sample resources BioSample; SAMN03473450
Chemistry resources GDSC; 1503364
PharmacoDB; SKGT2_1388_2019
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM1670430
Other Wikidata; Q54953659
Polymorphism and mutation databases IARC_TP53; 4078
Entry history
Entry creation04-Apr-2012
Last entry update20-May-2021
Version number21